Cargando…
The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model
BACKGROUND: SZ-123, a murine monoclonal antibody that targets the human von Willebrand factor (VWF) A3 domain and blocks the binding of collagen, is a powerful antithrombotic. In a Rhesus monkey model of thrombosis, SZ-123 had no side effects, such as bleeding or thrombocytopenia. METHODS: The mouse...
Autores principales: | Ji, Shundong, Jiang, Miao, Yan, Bin, Shen, Fei, He, Yang, Wan, Aini, Xia, Lijun, Ruan, Changgeng, Zhao, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438484/ https://www.ncbi.nlm.nih.gov/pubmed/28526067 http://dx.doi.org/10.1186/s13045-017-0475-2 |
Ejemplares similares
-
A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13
por: Zhang, Lulu, et al.
Publicado: (2017) -
Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010) -
Elevated Plasma von Willebrand Factor Antigen and Activity Levels Are Associated With the Severity of Coronary Stenosis
por: Yan, Bin, et al.
Publicado: (2020) -
A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13
por: Zhang, Jingyu, et al.
Publicado: (2011) -
Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13
por: Zhang, Jingyu, et al.
Publicado: (2011)